Recombinant factor VII [rFVII] can be useful for massive hemorrhage during radical nephrectomy
Anaesthesia, Pain and Intensive Care. 2015; 19 (2): 170-172
in En
| IMEMR
| ID: emr-166451
Responsible library:
EMRO
ABSTRACT
Radical nephrectomy for renal tumors can be associated with serious complications, e.g. massive bleeding or even table deaths. Various regimens like normovolemic hemodilution, autologous transfusion, hypotensive anesthesia, etc have been used in anticipation of hemorrhage in these operations. In our case there was not only massive hemorrhage but also a failure to clot and disseminated intravascular coagulation. All the routine regimens failed to stop bleeding and the generalized ooze. Recombinant Factor VII [rFVIIa] was used and it saved the day
Search on Google
Index:
IMEMR
Main subject:
Blood Transfusion
/
Recombinant Proteins
/
Factor VIIa
/
Hemorrhage
Type of study:
Case_reports
Limits:
Adult
/
Humans
/
Male
Language:
En
Journal:
Anaesth. Pain Intensive Care
Year:
2015